Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Triparental synthetic yeast hybrids as a platform for higher 2-phenylethanol yields and stress resistance.

Created on 06 Jul 2026

Authors

Karolina Drężek, Zsuzsa Antunovics, Maria Krystyna Sobczyk, Agnieszka Karolina Grabiec, Jolanta Mierzejewska

Published in

World journal of microbiology & biotechnology. Volume 42. Issue 7. Jul 06, 2026. Epub Jul 06, 2026.

Abstract

2‑Phenylethanol (2‑PE) is a valuable aromatic alcohol widely used in the cosmetic, food, and pharmaceutical industries, yet its cytotoxicity remains a major bottleneck for microbial production. In this study, we evaluated a set of previously constructed triple hybrid yeast strains (H1-H5), derived from S. cerevisiae 10‑170 and the double hybrid II/6, to assess their potential for enhanced 2‑PE biosynthesis and tolerance. Comprehensive phenotypic analysis revealed that the triple hybrids consistently outperformed both parental strains, reaching 2-PE titers of up to 3 g/L within 72 h across different cultivation media. Depending on the parental strain used for comparison and the medium composition, the hybrids showed even up to 9-fold higher 2-PE production. Increase in production was observed under all tested cultivation conditions, indicating a robust and reproducible phenotype. In addition, the hybrids displayed increased tolerance to externally supplied 2-PE; for example, strain H1 retained 61% of its growth relative to untreated controls in the presence of 4 g/L 2-PE. The hybrids effectively combined advantageous traits from both parents, inheriting high production capacity from II/6 and strong tolerance from S. cerevisiae 10‑170, in some cases exceeding both. These findings highlight multi‑parental hybridisation as a scalable, non‑GMO strategy for developing robust yeast cell factories for industrial 2‑PE production and broader biotechnological applications.

PMID:
42406181
Bibliographic data and abstract were imported from PubMed on 06 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement